If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Monday broker round-up

Mon, 16th Mar 2015 15:59
Bodycote: N+1 Singer downgrades to hold.Morrrison: Deutsche Bank lifts target to 210p from 190p and reiterates hold.Centrica: Deutsche Bank reiterates hold and 280p target price.Rio Tinto: HSBC downgrades to neutral.IGas Energy: Cannacord Genuity lowers target to 85p from 125p and reiterates buy.Hunting: Cannacord Genuity reiterates hold recommendation lowers target to 475p from 600p.AstraZeneca: Credit Suisse lowers target to 4,320p from 4,670p but reiterates underperform.Wolseley: UBS reiterates buy and hikes target to 4,500p from 3,980p.Afren: JP Morgan lowers target price to 4p from 33p while reiterating underweight.Shire: Credit Suisse raises target to 5,680p from 5,000p and reiterates outperform.Soco International: UBS lowers target to 150p from 260p and reiterates neutral. Astrazeneca Rio Tinto Bodycote Centrica

Shares in this article

Related News

LONDON MARKET CLOSE: FTSE 100 up as US jobs data eases rate hike fears
1 day ago

LONDON MARKET CLOSE: FTSE 100 up as US jobs data eases rate hike fears

(Alliance News) - European stocks soared on Thursday as weaker than expected US jobs figures dampened market worries of a near-term interest rate hike...

Market News BAE Systems + 15 more shares
Hutchmed drug approved in China for advanced gastric cancer
1 day ago

Hutchmed drug approved in China for advanced gastric cancer

(Alliance News) - Hutchmed China Ltd on Thursday announced regulatory approval for savolitinib, brand name 'ORPATHYS', for a form of gastric cancer wi...

Pharmaceuticals Hutchmed + 1 more share
AstraZeneca signs CSPC China deal for experimental kidney disease drugs
2 days ago

AstraZeneca signs CSPC China deal for experimental kidney disease drugs

July 2 (Reuters) - AstraZeneca ​has entered into a deal worth up to $1.77 billion ​with ‌CSPC Pharmaceutical Group to discover and develop experimenta...